Bibliografía del artículo
1. Ankun WM, Van der Veen F, Hamerlynk JVTH, Lammes FB. Transvaginal sonography and human chorionic gonadotrophin mensurements in suspected ectopic pregnancy; a detailed analysis of a diagnostic approach. Human Reproduction 8:1307-11, 1993.
2. Debby A, Golan A, Sadan O, Zakut H, Glezerman M. Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy. BJOG 107(5):626-30, 2000.
3. Rantala M, Mäkinen J. Tubal patency and fertility outcome after expectant management of ectopic pregnancy. Fertil Steril 68(6):1043-6, 1997.
4. Mol BWJ, Swart P, Bossut PMM, Van Der Veen F. Hysterosalpingography an important tool in predicting fertility outcome? Fertil Steril 67:663-9, 1997.
5. Stovall TG, Ling FW, Gray LA, Carson SA, Buster JE. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstet Gynecol 77:5, 1991.
6. Elito Junior J, Reichmann A, Uchiyama M, Camano L. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. Int J Gynecol Obstet 67:75-9, 1999.
7. Tamhane AC, Dunlop DD. Statistics and data analysis from elementary to intermediate. New Jersey, Prentice Hall, 2000.
8. Glatstein IZ, Sleeper LA, Lavy Y, Simon A, Adoni A, Palti Z, Hurwitz A, Laufer N. Observer variability in the diagnosis and management of the hysterosalpingogram. Fertil Steril 67:233-7, 1997.
9. Job-Spira N, Fernadez ZH, Bouyer J. Ruptured tubal ectopic pregnancy risk factors and reprodutive outcome: results of a population-based study in France. Am J Obstet Gynecol 180:938-44, 1999.
10. Mass JWM, Evers JLH, Riet G, Kessels AGH. Pregnancy rate following normal versus abnorrnal hysterosalpingography findings: a meta-analysis. Gynecol Obstet Invest 43:79-83, 1997.
11. Zohav E, Gemer O, Segal S. Reproductive outcome after expectante management of ectopic pregnancy. Eur J Obstet Reprod Biol 66(1):1-2, 1996.
12. Lipscomb GH, Maccord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate therapy for ectopic pregnancy. Obstet Gynecol 93:590-3, 1999.
13. Elito Jr J, Han KK, Camano L. Values of beta-human chorionic gonadotropin as a risk factor for tubal obstruction after tubal pregnancy. Acta Obstetricia et Gynecologica Scandinavica 84(9):864-867, 2005.